147 related articles for article (PubMed ID: 24451080)
21. Quantitative reverse transcription-polymerase chain reaction measurement of HASH1 (ASCL1), a marker for small cell lung carcinomas with neuroendocrine features.
Westerman BA; Neijenhuis S; Poutsma A; Steenbergen RD; Breuer RH; Egging M; van Wijk IJ; Oudejans CB
Clin Cancer Res; 2002 Apr; 8(4):1082-6. PubMed ID: 11948117
[TBL] [Abstract][Full Text] [Related]
22. Frequent loss of gelsolin expression in non-small cell lung cancers of heavy smokers.
Dosaka-Akita H; Hommura F; Fujita H; Kinoshita I; Nishi M; Morikawa T; Katoh H; Kawakami Y; Kuzumaki N
Cancer Res; 1998 Jan; 58(2):322-7. PubMed ID: 9443412
[TBL] [Abstract][Full Text] [Related]
23. Wnt3 gene expression promotes tumor progression in non-small cell lung cancer.
Nakashima N; Liu D; Huang CL; Ueno M; Zhang X; Yokomise H
Lung Cancer; 2012 May; 76(2):228-34. PubMed ID: 22070884
[TBL] [Abstract][Full Text] [Related]
24. C-CAM1, a candidate tumor suppressor gene, is abnormally expressed in primary lung cancers.
Wang L; Lin SH; Wu WG; Kemp BL; Walsh GL; Hong WK; Mao L
Clin Cancer Res; 2000 Aug; 6(8):2988-93. PubMed ID: 10955775
[TBL] [Abstract][Full Text] [Related]
25. Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer.
De Petris L; Orre LM; Kanter L; Pernemalm M; Koyi H; Lewensohn R; Lehtiö J
Lung Cancer; 2009 Mar; 63(3):410-7. PubMed ID: 18620780
[TBL] [Abstract][Full Text] [Related]
26. DNA hypermethylation at the D17S5 locus in non-small cell lung cancers: its association with smoking history.
Eguchi K; Kanai Y; Kobayashi K; Hirohashi S
Cancer Res; 1997 Nov; 57(21):4913-5. PubMed ID: 9354457
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
28. Expression of survivin mRNA and livin mRNA in non-small-cell lung cancer.
Tanabe H; Yagihashi A; Tsuji N; Shijubo Y; Abe S; Watanabe N
Lung Cancer; 2004 Dec; 46(3):299-304. PubMed ID: 15541814
[TBL] [Abstract][Full Text] [Related]
29. Molecular genetics of small cell lung carcinoma.
Wistuba II; Gazdar AF; Minna JD
Semin Oncol; 2001 Apr; 28(2 Suppl 4):3-13. PubMed ID: 11479891
[TBL] [Abstract][Full Text] [Related]
30. Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome.
Zhang L; Chen J; Ke Y; Mansel RE; Jiang WG
Int J Mol Med; 2006 May; 17(5):937-44. PubMed ID: 16596284
[TBL] [Abstract][Full Text] [Related]
31. The methylation status and protein expression of CDH1, p16(INK4A), and fragile histidine triad in nonsmall cell lung carcinoma: epigenetic silencing, clinical features, and prognostic significance.
Nakata S; Sugio K; Uramoto H; Oyama T; Hanagiri T; Morita M; Yasumoto K
Cancer; 2006 May; 106(10):2190-9. PubMed ID: 16598757
[TBL] [Abstract][Full Text] [Related]
32. Favorable prognosis of operable non-small cell lung cancer (NSCLC) patients harboring an increased expression of tumor endothelial markers (TEMs).
Pircher A; Fiegl M; Untergasser G; Heidegger I; Medinger M; Kern J; Hilbe W
Lung Cancer; 2013 Aug; 81(2):252-8. PubMed ID: 23664449
[TBL] [Abstract][Full Text] [Related]
33. Expression profiles of Toll-like receptors in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Samara KD; Antoniou KM; Karagiannis K; Margaritopoulos G; Lasithiotaki I; Koutala E; Siafakas NM
Int J Oncol; 2012 May; 40(5):1397-404. PubMed ID: 22344343
[TBL] [Abstract][Full Text] [Related]
34. Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancer.
Kadara H; Fujimoto J; Yoo SY; Maki Y; Gower AC; Kabbout M; Garcia MM; Chow CW; Chu Z; Mendoza G; Shen L; Kalhor N; Hong WK; Moran C; Wang J; Spira A; Coombes KR; Wistuba II
J Natl Cancer Inst; 2014 Mar; 106(3):dju004. PubMed ID: 24563515
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of survivin levels in circulation and tissue samples of lung cancer patients.
Kapellos G; Polonifi K; Farmakis D; Spartalis E; Tomos P; Aessopos A; Polizos A; Mantzourani M
Anticancer Res; 2013 Aug; 33(8):3475-80. PubMed ID: 23898122
[TBL] [Abstract][Full Text] [Related]
36. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer.
Yang J; Liu H; Wang H; Sun Y
Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213
[TBL] [Abstract][Full Text] [Related]
37. Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?
Carpagnano GE; Spanevello A; Palladino GP; Gramiccioni C; Ruggieri C; Carpagnano F; Foschino Barbaro MP
Lung Cancer; 2010 Jan; 67(1):108-13. PubMed ID: 19423183
[TBL] [Abstract][Full Text] [Related]
38. Never smokers with lung cancer: analysis of genetic variants.
Xiao H; Ding J; Gao S; Yang S; Huang Y
Asian Pac J Cancer Prev; 2011; 12(10):2807-9. PubMed ID: 22320997
[TBL] [Abstract][Full Text] [Related]
39. Live and let die: epigenetic modifications of Survivin and Regucalcin in non-small cell lung cancer tissues contribute to malignancy.
Nitschkowski D; Marwitz S; Kotanidou SA; Reck M; Kugler C; Rabe KF; Ammerpohl O; Goldmann T
Clin Epigenetics; 2019 Nov; 11(1):157. PubMed ID: 31718698
[TBL] [Abstract][Full Text] [Related]
40. RNA-sequencing in non-small cell lung cancer shows gene downregulation of therapeutic targets in tumor tissue compared to non-malignant lung tissue.
Reynders K; Wauters E; Moisse M; Decaluwé H; De Leyn P; Peeters S; Lambrecht M; Nackaerts K; Dooms C; Janssens W; Vansteenkiste J; Lambrechts D; De Ruysscher D
Radiat Oncol; 2018 Jul; 13(1):131. PubMed ID: 30016964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
